Attributed to the antidiabetic properties, metformin reduces circulating glucose and insulin, resulting in a decrease in cell proliferation and invasion; this is particularly effective in tumor with high expression of insulin receptors, such as breast cancer (Goodwin et al., 2012; Mallik and Chowdhury, 2018). This evidence concerns the gene INS and neoplasm.